Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery-Reference-Cited by-同舟云学术

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery

Published:2020-11 Issue: Volume:34 Page:100627
ISSN:2352-5789
Container-title:Gynecologic Oncology Reports
language:en
Short-container-title:Gynecologic Oncology Reports

Author:

Mullany Sally,Miller David Scott,Robison Katina,Levinson Kimberly,Lee Yi-Chun,Yamada S. Diane,Walker Joan,Markman Maurie,Marin Alyson,Mast Peter,diZerega Gere

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference15 articles.

1. Role of intraperitoneal therapy in the initial management of Ovarian cancer;Armstrong;J. Clin. Oncol.,2019

2. A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity;Cristea;Cancer Chemother. Pharmacol.,2019

3. Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy;Fujiwara;Cancer,2019

4. Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery;Goldberg;J. Pharm. Pharmacol.,2002

5. Front-line therapy of advanced ovarian cancer: new approaches;Ledermann;Ann. Oncol.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies;Oncology and Therapy;2024-01-30

2. Intratumoral Treatment of Melanoma Tumors with Large Surface Area Microparticle Paclitaxel and Synergy with Immune Checkpoint Inhibition;International Journal of Nanomedicine;2024-01

3. Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel;Pancreas;2023-03

4. Clinical Trials Involving Chemotherapy-Based Nanocarriers in Cancer Therapy: State of the Art and Future Directions;Cancer Nanotechnology;2022-12-14

5. Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer;Journal of Urology;2022-10